The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UK



Smith, Christopher, Smith, Emma, Chiu, Christopher, Hinton, Jay ORCID: 0000-0003-2671-6026, Perez Sepulveda, Blanca ORCID: 0000-0002-2891-4010, Gordon, Melita ORCID: 0000-0002-0629-0884, Choy, Robert KM, Hill, Peter WS, Meiring, James, Darton, Thomas
et al (show 4 more authors) (2023) The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UK. Wellcome Open Research, 8. 111-.

[img] PDF
Smith etal 2023 CHANTS study- Development of a human infection model - WellcomeOpenResearch.pdf - Open Access published version

Download (716kB) | Preview

Abstract

Invasive non-typhoidal Salmonella disease (iNTS) is a major cause of morbidity and mortality globally, particularly as a cause of bloodstream infection in children and immunocompromised adults in sub-Saharan Africa. Vaccines to prevent non-typhoidal Salmonella (NTS) would represent a valuable public health tool in this setting to avert cases and prevent expansion of antimicrobial resistance. Several NTS and combination typhoidal-NTS vaccine candidates are in early-stage development, although the pathway to licensure is unclear due to challenges in conducting large phase III field trials. Controlled human infection models (CHIM) present an opportunity to accelerate vaccine development for a range of enteric pathogens. Several recent typhoidal Salmonella CHIMs have been conducted safely and have played pivotal roles in progressing vaccine candidates to pre-qualification and licensure. The Challenge Non-Typhoidal Salmonella (CHANTS) consortium has been formed with funding from the Wellcome Trust, to deliver the first NTS CHIM, which can act as a platform for future vaccine evaluation. This paper reports the conclusions of a consultation group workshop convened with key stakeholders. The aims of this meeting were to: (1) define the rationale for an NTS CHIM (2) map the NTS vaccine pipeline (3) refine study design and (4) establish potential future use cases.

Item Type: Article
Uncontrolled Keywords: CHANTS Consortium
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 07 Nov 2023 10:34
Last Modified: 07 Nov 2023 10:35
DOI: 10.12688/wellcomeopenres.19012.2
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3176665